NCT06152146撤回不适用
Randomized Controlled Trial of Low Intensity Shockwaves Therapy for the Treatment of Post-Radical Prostatectomy Erectile Dysfunction. SHARP-ED TRIAL
适应症
试验速览
- 阶段
- 不适用
- 状态
- 撤回
- 试验地点
- 2
- 主要终点
- Change in number of participants reporting on Penetrative Intercourse
研究概览
简要总结
Research study designed to learn about and compare Shockwave therapy (SWT) vs placebo (no shockwaves) treatment in men with moderate to severe erectile dysfunction (ED) after Radical Prostatectomy
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- Double (Participant, Investigator)
入排标准
- 年龄范围
- 40 Years 至 75 Years（Adult, Older Adult）
- 性别
- Male
- 接受健康志愿者
- 否
入选标准
- •Be willing and able to provide informed consent.
- •Be ≥ 40 and ≤ 75 years of age (inclusive).
- •Undergo radical prostatectomy for prostate cancer (nerve sparing or non-nerve sparing without neoadjuvant chemotherapy or radiation therapy.)
- •Be at least six weeks post radical prostatectomy.
- •Be in a stable sexual relationship for over 3 months prior to enrollment.
- •Have testosterone level of 300-1000 ng/dL within 1 month prior to enrollment.
- •Have an HbA1c level ≤ 7% within 3 months prior to enrollment.
- •Have undetectable PSA value at the time of enrollment
排除标准
- •Be currently participating in a clinical trial or have recently received an investigational therapy within the past 30 days that may interfere with the results of this study.
- •Be under judicial protection (prison or custody).
- •Be an adult under guardianship.
- •Refuse to sign the informed consent.
- •Have evidence of venous leak prior to surgery or use of PDE5i prior to surgery
- •Have past radiation therapy of the pelvic region or hormonal therapy with androgen deprivation within 12 months prior to enrollment.
- •Be recovering from any cancer within 12 months prior to enrollment (other than prostate cancer)
- •Have Neurological disease such as Alzheimer's or Parkinson's disease which affects erectile function (at the discretion of the investigator).
- •Have a Psychiatric diagnosis or medications such as antidepressants, anxiolytic, antipsychotic that affects erectile function or any other medications (at the discretion of the investigator).
- •Have an anatomical malformation of the penis, including Peyronie's disease.
- •Have testosterone level <300 or >1000 ng/dL within 1 month prior to enrollment.
- •Be using blood thinners with international normalized ratio (INR) to be >
- •Have received shockwave therapy for at least 6 months before enrollment.
- •Have detectable PSA value after the radical prostatectomy.
- •Require radiation therapy after radical prostatectomy.
- •Require hormonal therapy after radical prostatectomy.
结局指标
主要结局
Change in number of participants reporting on Penetrative Intercourse
时间窗: Baseline to 6 months and Baseline to 12 months.
Number of participants reporting the ability to have penetrative intercourse with or without PDE5i but without the use of intracavernosal injections was chosen as the primary clinical efficacy assessment tool in this study.
次要结局
- Change in GAQ- Global Assessment Questions(Baseline to 6 months and Baseline to 12 months.)
- Change in Penile blood flow (Penile Duplex Ultrasound) measured in centimeters per second (cm/sec)(Baseline to 12 months.)
- Change in IIEF-EF Scores(Baseline to 6 months and Baseline to 12 months.)
- Change in SEP- Sexual Encounter Profile: Questions 2 and 3(Baseline to 6 months and Baseline to 12 months.)
- Change in EHS- Erection Hardness Score(Baseline to 6 months and Baseline to 12 months.)
研究者
Russell Saltzman
Regulatory Specialist
University of Miami
研究点 (2)
Loading locations...
相似试验
终止
不适用
Low Intensity Shockwaves Therapy for the Treatment of Erectile Dysfunction. 12- Month Follow-UpErectile DysfunctionNCT03670628University of Miami23
Unknown
2 期
LiST Plus PRP Injection Therapy vs LiST Monotherapy for ED TreatmentErectile DysfunctionNCT05366504Institute for the Study of Urological Diseases, Greece60
已完成
不适用
Low-intensity Shockwaves Therapy for the Treatment of Patients With Moderate Vasculogenic Erectile DysfunctionErectile DysfunctionNCT03518983Institute for the Study of Urological Diseases, Greece70
已完成
不适用
Low-intensity Shockwave Therapy for Non-bacterial Prostatitis/Pelvic Pain SyndromeChronic ProstatitisNCT03543761Institute for the Study of Urological Diseases, Greece45
已完成
不适用
Safety and Efficacy of Cardiac Shockwave Therapy in Patients Undergoing Coronary Artery Bypass GraftingHeart Failure PatientsCardiac IschemiaNCT03859466Medical University Innsbruck63